Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TERLIVAZ® safely and effectively. See full prescribing information for TERLIVAZ. TERLIVAZ (terlipressin) for injection, for intravenous use Initial U.S. Approval: 2022
Medication labelWhy this: Advisory · dailymed-prescription
TERLIVAZ is indicated to improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function. Limitation of Use Patients with a serum creatinine > 5 mg/dL are unlikely to experience benefit.
- generic_name
- terlipressin
- product_names
- Terlipressin
- ndc
- 43825-200, 43825-200-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en